Videos Videos of the IZB Neutralizing GDF-15: Development of a new class of anti-cancer immunotherapyFrom visionary to market leader in viral vectorsVegan silk for industrial productionEisbach Bio develops a drug against COVID-19Bind-X revolutionizes agriculture with biomineralizationLINDIS Biotech develops immunotherapy against bladder cancerNew liquid biopsy test from Exosome avoids many unpleasant prostate biopsies Videos IZBrunch IZBrunch, February 2023IZBrunch, November 2022IZBrunch vom 21. Juli 2022IZBrunch June 30, 2022IZBrunch, October 21, 2021IZBrunch, September 23, 2021 Videos Munich Life Science Pitch Day 8th Munich Life Science Pitch Day7th Munich Life Science Pitch Day6th Munich Life Science Pitch Day Videos of the Biotech Press Lounge 16th Biotech Press Lounge15th Biotech Press Lounge14th Biotech Press Lounge13th Biotech Press Lounge12th Biotech Press Lounge11th Biotech Press Lounge10th Biotech Press Lounge9th Biotech Presse-Lounge8th Biotech Presse-Lounge7th Biotech Press Lounge6th Biotech Press Lounge5th Biotech Press Lounge4th Biotech Press Lounge3rd Biotech Presse-Lounge To the current press releases 28. November 2023MoleQlar receives seed funding from Rheingau Founders and acquires Munich-based epigenetics specialist EpiQMAx6. November 2023Presentation of IZB’s innovation powerhouse in the context of BIO-Europe 202325. September 2023Dr. Peter Hanns Zobel, CEO of IZB, Bids Farewell Stay up-to-date: IZB top news Biotech press corner Contact us nowYOUR STARTUp at the izbUse the unique location for founding your start-up
